Histone deacetylase inhibitors possessing marked anticancer activity, low toxicity and oral bioavailability. Conference Paper uri icon

authors

  • Rephaeli, A
  • Brokhman, I
  • Blank-Porat, D
  • Entin-Meer, M
  • Cutts, S
  • Phillips, D
  • Hmelnitsky, I
  • Engel, D
  • Nudelman, A

publication date

  • 2003